Jim Cramer Admits He Was Wrong About CVS Health's (CVS) Aetna

We recently published Jim Cramer Discussed These 11 Stocks & The Market’s 3rd Bull Run Anniversary. CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently discussed.

CVS Health Corporation (NYSE:CVS) is one of the largest healthcare services and pharmacy companies in the US. The firm scored a major win last week when 81% of users of its Aetna service rated it four stars or higher. The data saw CVS Health Corporation (NYSE:CVS) pull ahead of major rivals such as UnitedHealth and Humana. These ratings allow insurers to potentially receive more in government bonus payments. Cramer has discussed the firm several times in 2025. For instance, in an August appearance, the CNBC TV host remarked that while he was uncertain about investing in the sector, for those interested, CVS Health Corporation (NYSE:CVS) might be the right option. During this appearance, he underscored the importance of the Aetna ratings and admitted that he was wrong about the service:

“Well this is the way America works. That’s why CVS could probably really break out here. Because Aetna did not have a plan that I thought was a killer plan. I was wrong.”

While we acknowledge the potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.